• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·MRMD
Share

MariMed Inc. Stocks

$ 0.07Last Updated 05.11.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 24.51M

$ 0.07
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

04.04.2025 14:24

Noble initiates on MariMed with ‘buy,’ citing 150% upside

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is of fair value on EV/EBITDA, un

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

06.11.2026 17:33

Investors have started buying back tech stocks, but concerns remain — online

06.11.2026 17:14

Neoclouds have keenly felt the shortage of AI funding. What should investors keep an eye on?

06.11.2026 16:01

"Flashbacks to 2008 or 2001": Are There Still "Bullish" Scenarios on Wall Street?

06.11.2026 15:43

Morning in New York: AI Stocks Enter a Period of Turbulence

06.11.2026 14:44

The sell-off of AI stocks has cast doubt on the timing of Anthropic's IPO. What does this mean for the market?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026